GRI Bio Analyst Price Targets - Benzinga

SPY779.43 QQQ758.21−0.19%BTC/USD84,139.00−1.65%DIA513.93 GLD378.32−1.03%TLT76.90−0.49%

GRI Bio Inc

GRINASDAQ

Trade with Public

Trade with Public

$1.90

-0.01-0.52%

Last update: Oct 5, 4:08 PM

$1.90

-0.01-0.52%

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Dividends Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

GRI Bio Analyst Price Targets - Benzinga

GRI Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for GRI Bio (GRI).

Price Target Range — 7 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingBuy# Analysts2Avg. Consensus PT$106Upside to Avg. PT+5461.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 10, 2026	HC Wainwright & Co.	Matthew Keller	Maintained	Buy	$10
Aug 21, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$32→$27
Jun 1, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$40→$32
Mar 11, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$1008→$40
Dec 8, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$35→$36
Sep 22, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$34→$35
Jun 11, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$10
May 27, 2025	Ascendiant Capital	Edward Woo	PT Cut	Buy	$40→$34
Apr 14, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$10
Dec 9, 2024	HC Wainwright & Co.	Joseph Pantginis	Initiate	Buy	$10
Dec 5, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$12→$13
Oct 8, 2024	Ascendiant Capital	Edward Woo	Initiate	Buy	$12

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on GRI Bio, Maintains $10 Price Target

HC Wainwright & Co. analyst Matthew Keller reiterates GRI Bio (NASDAQ:GRI) with a Buy and maintains $10 price target.

Benzinga Newsdesk

Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know

Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price targets raised/cut, ratings maintained/changed.

Avi Kapoor

PRO
Ascendiant Capital Maintains Buy on GRI Bio, Lowers Price Target to $32

Ascendiant Capital analyst Edward Woo maintains GRI Bio (NASDAQ:GRI) with a Buy and lowers the price target from $40 to $32.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on GRI Bio, Lowers Price Target to $40

Ascendiant Capital analyst Edward Woo maintains GRI Bio (NASDAQ:GRI) with a Buy and lowers the price target from $1008 to $40.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on GRI Bio, Raises Price Target to $36

Ascendiant Capital analyst Edward Woo maintains GRI Bio (NASDAQ:GRI) with a Buy and raises the price target from $35 to $36.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on GRI Bio, Raises Price Target to $35

Ascendiant Capital analyst Edward Woo maintains GRI Bio (NASDAQ:GRI) with a Buy and raises the price target from $34 to $35.

Benzinga Newsdesk